REG - Zotefoams PLC - Notification Of Transactions Of Directors/PDMRs

ZotefoamsAnnouncement

06/12/2022 09:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221206:nRSF7504Ia&default-theme=true

RNS Number : 7504I  Zotefoams PLC  06 December 2022

Zotefoams plc

(the 'Company')

 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs

6 December 2022 - On 5 December 2022, the Company received notice from its
Employee Benefit Trust of the exercise of nil cost options granted over
ordinary shares of 5 pence each ('Shares') under the Company's Deferred Bonus
Share Plan ('DBSP') at a sale price of £2.98 as follows:

 Director     Award      Number of shares exercised and retained  Aggregate number of shares held
 G C McGrath  DBSP 2020  23,021                                   94,261

 

Awards granted under the DBSP usually vest three years from grant, subject to
satisfaction of service conditions. However, given the unprecedented
circumstances brought about by COVID-19, and the decision of the Board not to
recommend a final dividend for the year ended 31 December 2019, the proportion
of the bonus that would normally have been paid in cash was deferred into
shares (the 'Deferred Bonus proportion'). The Remuneration Committee has
approved the exercise of the Deferred Bonus proportion taking place prior to
20 April 2023. The proportion of the bonus that would normally be deferred
into shares (25%) will continue as normal and will be released after three
years.

Under the terms of the award, the award was increased to reflect the dividends
paid during the restricted period.

The Notification of Dealing Form can be found below.

 

This announcement is made in accordance with the requirements of Article 19 of
the UK Market Abuse Regulation.

Lydia Harratt

Group Company Secretary

Zotefoams plc

020 8664 1600

 

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology
delivering optimal material solutions for the benefit of society. Utilising a
variety of unique manufacturing processes, including environmentally friendly
nitrogen expansion for lightweight AZOTE(®) polyolefin and ZOTEK(®)
high-performance foams, Zotefoams sells to diverse markets worldwide.
Zotefoams uses its own cellular materials to manufacture T-FIT(®) advanced
insulation for demanding industrial markets. Zotefoams also owns and licenses
patented microcellular foam technology to reduce plastic use in extrusion
applications and for ReZorce(®) mono-material recyclable barrier packaging.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites
in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam
products manufacture and conversion), Massachusetts, USA and Stilling, Denmark
(microcellular foam technology) and Jiangsu Province, China (T-FIT).

www.zotefoams.com (http://www.zotefoams.com)

AZOTE(®), ZOTEK(®), ReZorce(®) and T-FIT(®) are registered trademarks of
Zotefoams plc.

 

 

ZOTEFOAMS PLC

DEALING NOTIFICATION FORM

FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY
ASSOCIATED PERSONS

 

 1.  Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name: Gary Christopher McGrath
 2.  Reason for the notification
 a)  Position/status: Group CFO
 b)  Initial notification/Amendment: Initial notification
 3.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name:   Zotefoams plc
 b)  LEI: 213800B6P256B5XN8D32
 4.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument:

     Ordinary shares of 5 pence each

     Identification code: GB0009896605
 b)  Nature of the transaction: Exercise and retention under the Deferred Bonus
     Share Plan
 c)  Price(s) and volume(s):

Price(s)  Volume(s)
     £2.98     23,021
 d)  Aggregated information:

Aggregate Price  Aggregate Volume  Aggregate Total
     £2.98            23,021            £68,602.58
 e)  Date of the transaction: 5 December 2022
 f)  Place of the transaction: XLON

d)

Aggregated information:

 

 Aggregate Price  Aggregate Volume  Aggregate Total
 £2.98            23,021            £68,602.58

e)

Date of the transaction: 5 December 2022

f)

Place of the transaction: XLON

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHTFBLTMTIMMBT